ICD-10-CM Billable Code

Q90.0

Trisomy 21, nonmosaicism (meiotic nondisjunction)

Clinical Classification Guidelines

Medical Intelligence & Overview

Trisomy 21, also known as Down syndrome, is a genetic condition caused by an extra copy of chromosome 21. When it occurs as nonmosaicism, it means that every cell in the body has this additional chromosome due to meiotic nondisjunction. This condition can affect physical features, cognitive development, and overall health. Recognizing the features and implications of nonmosaic Trisomy 21 is important for understanding health management and support options available.

Causes & Symptoms

Clinical Causes: Meiotic nondisjunction during egg development, resulting in an extra chromosome 21 in the fertilized egg. Failure of chromosome 21 to separate properly during the formation of the egg or sperm. It is not typically inherited but occurs due to random errors in cell division.

Key Symptoms: Distinct facial features, including a flat facial profile, almond-shaped eyes that slant upwards, and a small nose. Low muscle tone (hypotonia) in infancy. Short stature and slower growth rates. A single deep crease across the palm of the hand (simian crease). Developmental delays and intellectual disabilities. Possible health issues such as heart defects, hearing problems, and vision impairments. Increased risk of gastrointestinal issues, such as intestinal blockage (atresia). Variations in immune system functioning, leading to increased susceptibility to infections.

Diagnostic & Treatment

Diagnosis Path: Diagnosis can be made prenatally through screening tests such as ultrasound and blood work, followed by confirmatory diagnostic tests like chorionic villus sampling (CVS) or amniocentesis, which analyze fetal chromosomes. After birth, a physical examination and a karyotype test—examining chromosomes under a microscope—are used to confirm the diagnosis and detect the presence of an extra chromosome 21.

Treatment Protocols: Developmental therapies, including physical, occupational, and speech therapy. Regular health monitoring to identify and treat health problems early. Educational support tailored to individual needs. Management of specific health issues such as heart defects or thyroid problems. Inclusive community support and specialized educational programs.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Q90.0 a billable ICD-10 code?
Yes, Q90.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Q90.0?
Clinical documentation must specify the nature of Trisomy 21, nonmosaicism (meiotic nondisjunction) and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

trisomy nonmosaicism